ArticleThe Lancet. Oncology2018
Targeting B-cell maturation antigen with GSK2857916 antibody-drug conjugate in relapsed or refractory multiple myeloma (BMA117159): a dose escalation and expansion phase 1 trial.
Suzanne Trudel et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
160 papers cite itlatest 60 shown
this paperpooled ittrialcites it